VASO Corp VASO

Vaso Corporation principally operates in three distinct business segments in the healthcare equipment and information technology industries. The company manages and evaluates its operations through these segments, which include IT services, professional sales of healthcare capital equipment, and the design and manufacture of proprietary medical devices and software. Vaso Corporation focuses on delivering technology-driven solutions and medical technology products to healthcare providers across the United States and select international markets.

Vaso Corporation generates revenue through the sale of managed network and security services, healthcare IT solutions, diagnostic imaging equipment and related service agreements, and proprietary medical devices such as cardiovascular monitoring and therapy systems. The company earns income from service contracts, product sales, and financing arrangements tied to medical equipment sales. Its customer base consists primarily of hospitals, clinics, physician practices, and other healthcare facilities seeking diagnostic, monitoring, and treatment technologies.

Vaso Corporation operates through the following segments: IT segment, Professional sales service segment, and Equipment segment.

• IT segment: This segment provides managed network infrastructure, transport, and security services through proprietary technology and third-party applications. It previously included healthcare IT application services until the divestiture of VasoHealthcare IT in November 2025. The segment operates through VasoTechnology, Inc. and its subsidiary NetWolves Network Services, LLC.
• Professional sales service segment: This segment focuses on the sale of GEHC diagnostic imaging equipment and ultrasound systems to healthcare providers in the United States. It also offers GEHC service agreements, training services, and third-party financial services for the equipment it sells. The segment operates through Vaso Diagnostics, Inc. d/b/a VasoHealthcare and employs over 90 sales professionals.
• Equipment segment: This segment designs, manufactures, sells, and services proprietary medical devices and software, including the Biox® series Holter monitors and ambulatory blood pressure recorders, ARCS® series analysis and reporting software for ECG and blood pressure signals, MobiCare® multi-parameter wireless vital-sign monitoring system, and EECP® therapy systems for non-invasive treatment of ischemic heart disease. The segment operates through VasoMedical, Inc., with domestic activities managed by VasoMedical Solutions, Inc. and international operations through Vasomedical Global Corp.

Vaso Corporation holds a competitive position in the healthcare technology and medical device industries through its proprietary technology, exclusive sales representation agreement with GEHC extending through 2030, and international regulatory certifications for its products. The company differentiates itself through its integrated approach to medical device development, in-house engineering, and global compliance with standards such as ISO 13485, CE marking, FDA clearances, and ANVISA approval. Its Biox® product line holds multiple international certifications, enhancing its global marketability.

Vaso Corporation serves hospitals, clinics, physician practices, and other healthcare providers in the United States and internationally. In the U. S., it sells GEHC diagnostic imaging equipment to accounts across the 48 contiguous states, Alaska, and the District of Columbia. Its proprietary medical devices are sold directly in the U. S. and China and through independent distributors in other international markets. The company also provides managed network services to healthcare and commercial clients via its NetWolves operations.